Expertise in
4
conditions

Dr. Robert L. Sorenson

Sorenson & Sorenson MDs
Sorenson Vision
Berkeley, CA
Expertise in
4
conditions
Specialties:Ophthalmology
Expertise in
4
conditions
OverviewInsuranceLocationsClinical Research

Overview

Robert Sorenson is an Ophthalmologist in Berkeley, California. Dr. Sorenson is highly rated in 4 conditions, according to our data. His top areas of expertise are Cataract, Conjunctivitis (Pink Eye), Eyelid Bump, and Meibomianitis.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Ophthalmology
Licenses
Ophthalmology in CA
Hospital Affiliations
Alta Bates Summit Medical Center - Alta Bates Camp
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Humana

Locations

Sorenson Vision
3010 Colby Street, Suite #114, Berkeley, CA 94705
510-204-4444
Other Locations
Sorenson Vision
3010 Colby Street, Suite #114, Berkeley, CA 94705
510-848-1413
Sorenson Vision
481 30th Street, Oakland, CA 94609
510-835-4521

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Multicenter, Randomized, Double-Masked Study To Compare The Ocular Safety, Tolerability, And Efficacy Of A Topical 0.2% Ophthalmic Corticosteroid Solution (SURF-201) To Vehicle In Cataract Surgery Subjects
A Multicenter, Randomized, Double-Masked Study To Compare The Ocular Safety, Tolerability, And Efficacy Of A Topical 0.2% Ophthalmic Corticosteroid Solution (SURF-201) To Vehicle In Cataract Surgery Subjects
Enrollment Status: Completed
Publish Date: January 15, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Masked Study To Evaluate The Safety, Tolerability, And Efficacy Of SURF-100 Ophthalmic Solution (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination) In Subjects With Dry Eye Disease
A Multicenter, Randomized, Double-Masked Study To Evaluate The Safety, Tolerability, And Efficacy Of SURF-100 Ophthalmic Solution (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination) In Subjects With Dry Eye Disease
Enrollment Status: Completed
Publish Date: February 16, 2023
Intervention Type: Drug
Study Drugs: Combination of Mycophenolic Acid and Betamethasone Sodium Phosphate, Mycophenolic Acid, Restasis Ophthalmic Emulsion, Xiidra Ophthalmic Solution
Study Phase: Phase 2
The CLEAN Study: Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization-A Prospective Cohort Study of Combination Therapy in the Treatment of Dry Eye
The CLEAN Study: Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization-A Prospective Cohort Study of Combination Therapy in the Treatment of Dry Eye
Enrollment Status: Completed
Publish Date: January 04, 2023
Intervention Type: Drug
Study Phase: Phase 3
The DEPOT Study (Dry Eye Prescription Options for Therapy): A Randomized Controlled Clinical Trial Assessing the Efficacy and Safety of DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert, When Placed Within the Lower Eye Eyelid Canaliculus in Comparison to Topical Loteprednol Suspension for the Treatment of Episodic Dry Eye
The DEPOT Study (Dry Eye Prescription Options for Therapy): A Randomized Controlled Clinical Trial Assessing the Efficacy and Safety of DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert, When Placed Within the Lower Eye Eyelid Canaliculus in Comparison to Topical Loteprednol Suspension for the Treatment of Episodic Dry Eye
Enrollment Status: Completed
Publish Date: January 03, 2022
Intervention Type: Drug
Study Phase: Phase 4
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis
Enrollment Status: Completed
Publish Date: June 09, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Efficacy of KPI-121 1.0% Ophthalmic Suspension in Subjects With Postsurgical Inflammation and Pain
A Phase 3, Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Efficacy of KPI-121 1.0% Ophthalmic Suspension in Subjects With Postsurgical Inflammation and Pain
Enrollment Status: Completed
Publish Date: December 16, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

1 Total Publications

Toxic anterior segment syndrome caused by autoclave reservoir wall biofilms and their residual toxins.
Toxic anterior segment syndrome caused by autoclave reservoir wall biofilms and their residual toxins.
Journal: Journal of cataract and refractive surgery
Published: March 15, 2016
Similar Doctors
Expertise in
37
conditions
Dr. Jacque L. Duncan
Ophthalmology
Expertise in
37
conditions
Dr. Jacque L. Duncan
Ophthalmology

Ucsf Medical Group Business Services

3100 San Pablo Ave, 
Berkeley, CA 
 (1.6 mi)
510-985-5020
Languages Spoken:
English
See accepted insurances

Jacque Duncan is an Ophthalmologist in Berkeley, California. Dr. Duncan is highly rated in 37 conditions, according to our data. Her top areas of expertise are Usher Syndrome Type 2A, Usher Syndrome, Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, and Vitrectomy.

Expertise in
33
conditions
Dr. Jay M. Stewart
Ophthalmology
Expertise in
33
conditions
Dr. Jay M. Stewart
Ophthalmology

Ucsf Medical Group Business Services

400 Parnassus Ave, 
San Francisco, CA 
 (12.6 mi)
Languages Spoken:
English
See accepted insurances

Jay Stewart is an Ophthalmologist in San Francisco, California. Dr. Stewart is highly rated in 33 conditions, according to our data. His top areas of expertise are Retinal Detachment, Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Trabeculectomy.

Expertise in
23
conditions
Dr. Theodore Leng
Ophthalmology
Expertise in
23
conditions
Dr. Theodore Leng
Ophthalmology

Stanford Health Care

300 Pasteur Dr, 
Stanford, CA 
 (29.5 mi)
650-723-4000
Languages Spoken:
English

Theodore Leng is an Ophthalmologist in Stanford, California. Dr. Leng is highly rated in 23 conditions, according to our data. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Trabeculectomy.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
    • Distinguished
    • Cataract
    • Advanced
    • Conjunctivitis (Pink Eye)
    • Eyelid Bump
    • Meibomianitis
    • Experienced
    • Age-Related Macular Degeneration (ARMD)
    • Allergic Conjunctivitis
    • Blocked Tear Duct
    • Dry Eye Syndrome
    • Endophthalmitis
    • Glaucoma
    View All 9 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Looking for the best doctor for you?
    Start Here
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    1. Homepage
    2. Ophthalmologists Berkeley, CA
    3. Dr. Robert L. Sorenson
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Life Sciences
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved

    Request a Doctor Appointment

    Please fill out the details in the form below to allow MediFind to submit an appointment request to Dr. Robert L. Sorenson's office on your behalf. Your provider may contact you directly to complete scheduling. This form is for appointment requests only. Currently, we are not accepting appointments from users outside of the US.

        0 / 1000

        Please provide us with the below insurance information:

        By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.